<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01042301</url>
  </required_header>
  <id_info>
    <org_study_id>BRD07/5-A</org_study_id>
    <nct_id>NCT01042301</nct_id>
  </id_info>
  <brief_title>Profiling of Original Cellular and Humoral Biomarkers of Type 1 Diabetes</brief_title>
  <acronym>Lymphoscreen</acronym>
  <official_title>Profiling of Original Cellular and Humoral Biomarkers of Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The &quot;Lymphoscreen&quot; study aims to characterize precisely (phenotypes/cytokines/functions) CD8+
      T cell responses in type 1 Diabetes to identify biomarkers of the disease. Such markers are
      needed for refine type 1 Diabetes diagnosis/prognostic, and to design new therapeutic
      approaches targeting autoreactive CD8+ T cells. An original approach using DNA immunization
      of humanized mice allowed us to identify relevant CD8 epitopes derived from GAD65 and IA-2
      beta cell autoantigens. The aims are: (i) identifying exhaustively epitopes recognized by
      autoreactive CD8+ T lymphocytes in type 1 Diabetes and following islet or pancreas graft in
      humans; (ii) identifying pathogenic CD8+ T cell patterns or profiles related to type 1
      Diabetes pathogenesis and evolution; (iii) correlating CD8+ autoreactive T cell responses and
      autoantibody responses to new cellular (such as CD4+ T cells or peripheral cell miRNA) or
      humoral markers of the disease (such as serum miRNA).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification and characterization of new CD8+ T lymphocytes related to type 1 diabetes and its evolution (2009-2012)</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification and characterization of new profiles of humoral and cellular markers (including T cell reactivity and miRNA) related to type 1 diabetes (2010-2014).</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Long-term type 1 diabetic patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Long-term type 1 diabetic patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diabetic and transplanted patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>diabetic and transplanted patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subjects with high risk for diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects with high risk for diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with recent type 1 diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with recent type 1 diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with Latent Autoimmune Diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with Latent Autoimmune Diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood samplings</intervention_name>
    <arm_group_label>Long-term type 1 diabetic patients</arm_group_label>
    <arm_group_label>control patients</arm_group_label>
    <arm_group_label>diabetic and transplanted patients</arm_group_label>
    <arm_group_label>subjects with high risk for diabetes</arm_group_label>
    <arm_group_label>patients with recent type 1 diabetes</arm_group_label>
    <arm_group_label>patients with Latent Autoimmune Diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  at least, 50 patients with &quot;recent&quot; type 1 diabetes,

          -  30 patients with long-term type 1 diabetes,

          -  10 patients with Latent Autoimmune Diabetes,

          -  10 subjects with a risk for diabetes,

          -  20 type 1 diabetic patients with pancreatic graft or Langerhans islet graft.

          -  50 healthy subjects paired to HLA class I and to the age

        Those subjects have to respect the following criteria :

          -  Age from 7 to 70 -Caucasian

          -  Affiliated to a national insurance scheme

          -  Written informed consent obtained For children, written informed consent is required
             from the two parents.

        Non-inclusion criteria :

          -  Age strictly inferior to 7 or strictly superior to 70 years old

          -  Pregnancy

          -  Secondary diabetes

          -  No written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucy Chaillous</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2010</study_first_submitted>
  <study_first_submitted_qc>January 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2010</study_first_posted>
  <last_update_submitted>September 7, 2015</last_update_submitted>
  <last_update_submitted_qc>September 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

